English Polski

Advanced search

Vol 25, No 1 (2019)
Articles
Published online: 2019-03-12

open access

View PDF Download PDF file
Page views 1291
Article views/downloads 911
Get Citation

Connect on Social Media

Connect on Social Media

The review of selected biomarkers of abdominal aortic aneurysm

Stanisław Surma1, Marta Lesiak1, Beata Dorzak2, Grzegorz Bajor2
DOI: 10.5603/AA.2019.0004
Acta Angiologica 2019;25(1):19-27.

Abstract

Abdominal aortic aneurysm (AAA) is a disease affecting the main artery transporting oxidized blood to the
abdominal and pelvic organs. Abdominal aortic aneurysms occur 4-8 times more often in men than in women,
usually develop after the age of 55. Among men over 65, 4–7.6%, this diagnosis can be expected. More aneurysms
occur in Caucasian people. Among the most frequently mentioned in the literature, AAA risk factors are
older age, male gender, positive family history, smoking, chronic obstructive pulmonary disease, hypertension,
hypercholesterolemia, peripheral arterial occlusive disease, ischemic heart disease. Biochemical tests to determine
the level of AAA-specific markers appear with potential. There are reports in the literature on the possible
use of concentrations of selected molecules in the diagnosis of AAA. According to cadaveric research, there are
noticed dimensions of the abdominal aorta at its different levels. The relation between aortic size and shape
can be the factor contributing to the development of AAA. Previous studies have shown that the development
of AAA is a crucial fundamental inflammatory response in conjunction with proteolysis tissue, which causes the
destruction and reconstruction of the blood vessel wall. Numerous factors contribute to the pathogenesis of
AAA: proteins, transcription factors, enzymes and microRNAs. The increase in the concentration of most factors
is associated with inflammation. The biomarkers presented in the paper are not limited to AAA, and thus can
be used only for visual assessment of the degree of abdominal aortic aneurysm development.

Keywords: abdominal aortic aneurysmAAA-specific markersinflammationrisk factorsbiomarkers

Article available in PDF format

View PDF Download PDF file

References

  1. Siwko A, Hendiger W, Eberhardt A, et al. Parametryzacja wymiarów tętniaków aorty brzusznej w materiale Kliniki Chirurgii Naczyniowej i Angiologii Centrum Medycznego Kształcenia Podyplomowego Szpitala Bielańskiego w Warszawie. Post N Med. 2016; XXIX(11B): 21–24.
  2. Johnston KW, Rutherford RB, Tilson MD, et al. Suggested standards for reporting on arterial aneurysms. Subcommittee on Reporting Standards for Arterial Aneurysms, Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery. J Vasc Surg. 1991; 13(3): 452–458.
    PubMed
  3. Cameron JL. Current surgical therapy. 7th ed. Mosby, St Louis 2001: 807–812.
  4. Oszkinis G. Znaczenie czynnika zapalnego w patogenezie tętniaka aorty brzusznej; praca habilitacyjna, AM w Poznaniu, 2000, 11–12; 54–56; 60–122.
  5. Kent KC. Clinical practice. Abdominal aortic aneurysms. N Engl J Med. 2014; 371(22): 2101–2108.
    CrossRefPubMed
  6. Karwowska A, Kurianiuk A, Łapiński R. Epidemiology of abdominal aortic aneurysm. Prog Health Sci . 2015; 5(1): 238–245.
  7. Barratt-Boyes BG. Symptomatology and prognosis of abdominal aortic aneurysm. The Lancet. 1957; 270(6998): 716–159.
    CrossRef
  8. Millar AJ, Gilbert RD, Brown RA, et al. Abdominal aortic aneurysms in children. J Pediatr Surg. 1996; 31(12): 1624–1628.
    PubMed
  9. http://www.mp.pl/interna/chapter/B16.II.2.22. (4.01.2019).
  10. Januszewicz W, Grodzicki T, Sitkowska-Janaszek H, et al. Nadciśnienie tętnicze — czynnik ryzyka rozwoju tętniaka aorty brzusznej. Arterial Hypertension. 2005; 9(6): 469–473.
  11. Frómankiewicz B, Jawień A. Rola badań przesiewowych we wczesnym wykrywaniu tętniaka aorty brzusznej. Acta Angiol. 2012; 18(1): 1–8.
  12. Siennicka A, Jastrzębska M. Rola homocysteiny w patogenezie tętniaka aorty brzusznej. Journal of Laboratory Diagnostics. 2012; 48(4): 413–422.
  13. Czyżewska – Bu, Żuk N, Bałasz S, et al. Ocena stężenia osteopontyny i osteoprotegryny u chorych z tętniakiem aorty brzusznej. Przegląd Lekarski. 2013; 70(3): 102–105.
  14. Licholai S, Szczeklik W, Sanak M. miR-29c-3p is an Effective Biomarker of Abdominal Aortic Aneurysm in Patients Undergoing Elective Surgery. Microrna. 2016; 5(2): 124–131.
    PubMed
  15. Maegdefessel L, Spin JM, Tsao PS. New ways to dismantle a ticking time bomb: microRNA 712/205 and abdominal aortic aneurysm development. Arterioscler Thromb Vasc Biol. 2014; 34(7): 1339–1340.
    CrossRefPubMed
  16. Oszkinis G, Kamiński J, Gabriel M, et al. Wartość oznaczania cytokin prozapalnych oraz zmian ilościowych białka ostrej fazy u chorych z tętniakiem aorty brzusznej. Chirurgia Polska. 2007; 9(4): 223–230.
  17. Gacko M, Łapiński R, Guzowski A, et al. Aktywność i stężenie inhibitorów proteinaz osocza krwi chorych z tętniakiem aorty brzusznej. Chirurgia Polska. 2003; 5(4): 189–193.
  18. Pahl MC, Erdman R, Kuivaniemi H, et al. Transcriptional (ChIP-Chip) Analysis of ELF1, ETS2, RUNX1 and STAT5 in Human Abdominal Aortic Aneurysm. Int J Mol Sci. 2015; 16(5): 11229–11258.
    CrossRefPubMed
  19. Choke E, Cockerill G, Wilson WRW, et al. A review of biological factors implicated in abdominal aortic aneurysm rupture. Eur J Vasc Endovasc Surg. 2005; 30(3): 227–244.
    CrossRefPubMed
  20. Ailawadi G, Eliason JL, Upchurch GR. Current concepts in the pathogenesis of abdominal aortic aneurysm. J Vasc Surg. 2003; 38(3): 584–588.
    PubMed
  21. Guzik B, Ignacak A, Anders M, et al. Czynniki ryzyka i etiopatogeneza tętniaków aorty brzusznej. Czynniki Ryzyka. 2012; 1: 6–16.
  22. Refsum H, Smith AD, Ueland PM, et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem. 2004; 50(1): 3–32.
    CrossRefPubMed
  23. Piotrkowska R, Landowska A, Książek J, et al. Methods for surgical treatment of abdominal aortic aneurysm – therapeutic and nursing implications. Medycyna Rodzinna. 2015; 1: 28–33.
  24. Szmidt J, Jakimowicz T. Postępy w leczeniu tętniaków aorty brzusznej. Postępy Nauk Medycznych. 2012; 1: 37–43.
  25. Mandal L, Mukhopadhyay P, Roy T, et al. Impact and biomechanical mechanisms of tortuosity of abdominal aorta — a case report. Natl J Med Res. 2016; 6(2): 219–221.
  26. Lopamudra M, Paramita M, Tapati R, et al. Impact and biomechanical mechanisms of tortuosity of abdominal aorta — a case report. N J Medical Research. 2016; 6(2): 219–221.
  27. Newman DL, Gosling RG, Bowden NL. Changes in aortic distensibility and area ratio with the development of atherosclerosis. Atherosclerosis. 1971; 14(2): 231–240.
    PubMed
  28. Liu Q, Han HC. Mechanical buckling of artery under pulsatile pressure. J Biomech. 2012; 45(7): 1192–1198.
    CrossRefPubMed
  29. Han HC. Nonlinear buckling of blood vessels: a theoretical study. J Biomech. 2008; 41(12): 2708–2713.
    CrossRefPubMed
  30. Marfuni G. Biomechanism of abdominal aortic aneurysym: Experimental evidence and multiscale constitutive modeling. Doctoral thesis no. 80 KTH School of Engineering Sciences Department of Solid Mechanics Royal Institute of Technology SE-100 44 Stockholm Sweden. : 2012.
  31. Davies MJ. Aortic aneurysm formation: lessons from human studies and experimental models. Circulation. 1998; 98(3): 193–195.
    PubMed
  32. Carey DJ. Control of growth and differentiation of vascular cells by extracellular matrix proteins. Annu Rev Physiol. 1991; 53: 161–177.
    CrossRefPubMed
  33. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD. Molecular biology of the cell. Garland Publishing, Ypsilanti 1994: Garland.
  34. Humphrey JD. Remodeling of a collagenous tissue at fixed lengths. J Biomech Eng. 1999; 121(6): 591–597.
    PubMed
  35. Nissen R, Cardinale GJ, Udenfriend S. Increased turnover of arterial collagen in hypertensive rats. Proc Natl Acad Sci U S A. 1978; 75(1): 451–453.
    PubMed
  36. Bashey RI, Cox R, McCann J, et al. Changes in collagen biosynthesis, types, and mechanics of aorta in hypertensive rats. J Lab Clin Med. 1989; 113(5): 604–611.
    PubMed
  37. Vorp DA, Raghavan ML, Webster MW. Mechanical wall stress in abdominal aortic aneurysm: influence of diameter and asymmetry. J Vasc Surg. 1998; 27(4): 632–639.
    PubMed
  38. Berillis P. The Role of Collagen in the Aorta's Structure. The Open Circulation and Vascular Journal. 2013; 6(1): 1–8.
    CrossRef
  39. Holmes DR, Liao S, Parks WC, et al. Medial neovascularization in abdominal aortic aneurysms: a histopathologic marker of aneurysmal degeneration with pathophysiologic implications. J Vasc Surg. 1995; 21(5): 761–71; discussion 771.
    PubMed
  40. Juvonen J, Surcel HM, Satta J, et al. Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 1997; 17(11): 2843–2847.
    PubMed
  41. Jones KG, Brull DJ, Brown LC, et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation. 2001; 103(18): 2260–2265.
    PubMed
  42. Tamarina NA, McMillan WD, Shively VP, et al. Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. Surgery. 1997; 122(2): 264–71; discussion 271.
    PubMed
  43. Thompson RW, Parks WC. Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann N Y Acad Sci. 1996; 800: 157–174.
    PubMed
  44. Tilson MD. Aortic aneurysms and atherosclerosis. Circulation. 1992; 85(1): 378–379.
    CrossRef
  45. Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Circ Res. 2001; 89(9): 763–771.
    PubMed
  46. Ailawadi G, Eliason JL, Upchurch GR. Current concepts in the pathogenesis of abdominal aortic aneurysm. J Vasc Surg. 2003; 38(3): 584–588.
    PubMed
  47. Naruszewicz M. Aktualne spojrzenie na rolę hiperhomocysteinemii w patogenezie miażdżycy. Pol Prz Neurol. 2005; 1(1): 19–22.
  48. Costantino TG, Bruno EC, Handly N, et al. Accuracy of emergency medicine ultrasound in the evaluation of abdominal aortic aneurysm. J Emerg Med. 2005; 29(4): 455–460.
    CrossRefPubMed
  49. Wassef M, Baxter BT, Chisholm RL, et al. Pathogenesis of abdominal aortic aneurysms: a multidisciplinary research program supported by the National Heart, Lung, and Blood Institute. J Vasc Surg. 2001; 34(4): 730–738.
    CrossRefPubMed
  50. Kraczkowska S, Suchocka Z, Pachecki J. Podwyższone stężenie homocysteiny we krwi jako wskaźnik zagrożenia zdrowia. Biul Wydz Farm AMW. 2005; 3: 4–13.
  51. Li JJ, Fang CH. Atheroscleritis is a more rational term for the pathological entity currently known as atherosclerosis. Med Hypotheses. 2004; 63(1): 100–102.
    CrossRefPubMed
  52. Ferrara F, Novo S, Grimaudo S, et al. Methylenetetrahydrofolate reductase mutation in subjects with abdominal aortic aneurysm subdivided for age. Clin Hemorheol Microcirc. 2006; 34(3): 421–426.
    PubMed
  53. Palko-Łabuz A, Sadakierska-Chudy A, Pilecki W. The genetic background of thrombosis - the distributions of factor V Leiden, prothrombin G20210A, and MTHFR C677T polymorphisms. Adv Clin Exp Med. 2010; 19: 51–55.
  54. Cao H, Hu X, Zhang Q, et al. Homocysteine level and risk of abdominal aortic aneurysm: a meta-analysis. PLoS One. 2014; 9(1): e85831.
    CrossRefPubMed
  55. Brunelli T, Prisco D, Fedi S, et al. High prevalence of mild hyperhomocysteinemia in patients with abdominal aortic aneurysm. J Vasc Surg. 2000; 32(3): 531–536.
    CrossRefPubMed
  56. Millo B, Wiernicki I, Bukowska H, et al. 2P-0380 Serum homocysteine and MCP-1 are associated with abdominal aortic aneurysm size and interluminal thrombus dimension. Atherosclerosis Supplements. 2003; 4(2): 122.
    CrossRef
  57. Schoppet M, Preissner KT, Hofbauer LC. RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function. Arterioscler Thromb Vasc Biol. 2002; 22(4): 549–553.
    PubMed
  58. Demer LL, Tintut Y. Mechanisms linking osteoprosis and cardiovascular calcification. Curr Osteoporos Rep. 2009; 7(2): 42–46.
  59. Knudsen ST, Foss CH, Poulsen PL, et al. Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications. Eur J Endocrinol. 2003; 149(1): 39–42.
    PubMed
  60. Nagasaka A, Matsue H, Matsushima H, et al. Osteopontin is produced by mast cells and affects IgE-mediated degranulation and migration of mast cells. Eur J Immunol. 2008; 38(2): 489–499.
    CrossRefPubMed
  61. Witkiewicz W, Czyżewska-Buczyńska A, Bałasz S, et al. Rola osteopontyny w chorobach serco¬wo-naczyniowych. Pol Merk Lek. 2010; 170: 79.
  62. Kim CW, Kumar S, Son DJu, et al. Prevention of abdominal aortic aneurysm by anti-microRNA-712 or anti-microRNA-205 in angiotensin II-infused mice. Arterioscler Thromb Vasc Biol. 2014; 34(7): 1412–1421.
    CrossRefPubMed
  63. Jung P, Zimowska M. Metaloproteinazy macierzy zewnątrzkomórkowej w rozwoju, fizjologii i procesach degeneracyjnych mięśni szkieletowych. Postępy Biochemii. 2016; 1(62): 25–35.
  64. Boon RA, Seeger T, Heydt S, et al. MicroRNA-29 in aortic dilation: implications for aneurysm formation. Circ Res. 2011; 109(10): 1115–1119.
    CrossRefPubMed
  65. Tokarz-Deptuła B, Miller T, Deptuła W. Cytokiny z rodziny interleukiny 1. Post Mikrobiol. 2011; 50(3): 217–221.
  66. Marnell L, Mold C, Du Clos TW. C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol. 2005; 117(2): 104–111.
    CrossRefPubMed
  67. Crowther M, Goodall S, Jones JL, et al. Increased matrix metalloproteinase 2 expression in vascular smooth muscle cells cultured from abdominal aortic aneurysms. J Vasc Surg. 2000; 32(3): 575–583.
    CrossRefPubMed
  68. Gacko M, Chyczewski L, Chrostek L. Distribution, activity and concentration of cathepsin B and cystatin C in the wall of aortic aneurysm. Pol J Pathol. 1999; 50(2): 83–86.
    PubMed
  69. Gacko M, Worowska A, Głowiński S. Aktywność proteolityczna i antyproteolityczna ściany tętniaka i aorty zmienionej miażdżycowo. Pamiętnik 56 Zjazd Tow. Chir. Pol., Lublin 1993; 4: 1632–1635. 1993.
  70. Jean-Claude J, Newman KM, Li H, et al. Possible key role for plasmin in the pathogenesis of abdominal aortic aneurysms. Surgery. 1994; 116(2): 472–478.
    PubMed
  71. Lindholt JS, Erlandsen EJ, Henneberg EW. Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms. Br J Surg. 2001; 88(11): 1472–1475.
    CrossRefPubMed
  72. Shah P. Inflammation, Metalloproteinases, and Increased Proteolysis. Circulation. 1997; 96(7): 2115–2117.
    CrossRef
  73. Skóra J, Janczak D, Barć P, et al. Badanie poziomu elastyny w ścianie tętniaków aorty brzusznej. Pol Merk Lek. 2000; 9: 552–553.
  74. Tamarina NA, McMillan WD, Shively VP, et al. Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. Surgery. 1997; 122(2): 264–271.
    PubMed
  75. Thompson RW, Parks WC. Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann N Y Acad Sci. 1996; 800: 157–174.
    PubMed
  76. Badmer JL, Schnebli HP. Plasma proteinase inhibitors. Schweiz Med Wsch. 1984; 114: 1359–1363.
  77. Ikari Y, Mulvihill E, Schwartz SM. alpha 1-Proteinase inhibitor, alpha 1-antichymotrypsin, and alpha 2-macroglobulin are the antiapoptotic factors of vascular smooth muscle cells. J Biol Chem. 2001; 276(15): 11798–11803.
    CrossRefPubMed
  78. Lindholt JS, Jørgensen B, Fasting H, et al. Plasma levels of plasmin-antiplasmin-complexes are predictive for small abdominal aortic aneurysms expanding to operation-recommendable sizes. J Vasc Surg. 2001; 34(4): 611–615.
    CrossRefPubMed
  79. Hinterseher I, Erdman R, Donoso LA, et al. Role of complement cascade in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 2011; 31(7): 1653–1660.
    CrossRefPubMed
  80. Gallant S, Gilkeson G. ETS transcription factors and regulation of immunity. Arch Immunol Ther Exp (Warsz). 2006; 54(3): 149–163.
    CrossRefPubMed
  81. Nottingham WT, Jarratt A, Burgess M, et al. Runx1-mediated hematopoietic stem-cell emergence is controlled by a Gata/Ets/SCL-regulated enhancer. Blood. 2007; 110(13): 4188–4197.
    CrossRefPubMed
  82. Mahmud SA, Manlove LS, Farrar MA. Interleukin-2 and STAT5 in regulatory T cell development and function. JAKSTAT. 2013; 2(1): e23154.
    CrossRefPubMed

About cookies

Necessary cookies

Allways active

These cookies are necessary for the proper display and operation of the website. Blocking them may cause the website to malfunction.

Analytical cookies

As part of our website, we use analytical tools, such as Google Analytics, that allow us to verify website traffic. These tools may require the use of cookies.

Community cookies

These are cookies associated with the social networks we use. Accepting them will allow us to associate your visit to the site with our social media profiles.

Marketing cookies

These are cookies responsible for carrying out advertising and marketing activities - consenting to their use will allow us to target you with advertisements based on your previous activities within our website.

Acta Angiologica

About Via Medica Advertising
Bookstore (Ikamed) TVMed
News
Copyright © 2023 Via Medica Regulations Cookie policy Privacy policy Legal Notice